224 related articles for article (PubMed ID: 28053982)
1. A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.
Carvalho MI; Silva-Carvalho R; Pires I; Prada J; Bianchini R; Jensen-Jarolim E; Queiroga FL
Biomed Res Int; 2016; 2016():4917387. PubMed ID: 28053982
[TBL] [Abstract][Full Text] [Related]
2. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.
Nosalova N; Huniadi M; Horňáková Ľ; Valenčáková A; Horňák S; Nagoos K; Vozar J; Cizkova D
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474142
[TBL] [Abstract][Full Text] [Related]
3. The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis.
Vafaizadeh V; Peuhu E; Mikkola ML; Khaled WT; Bentires-Alj M; Koledova Z
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):201-206. PubMed ID: 31494779
[TBL] [Abstract][Full Text] [Related]
4. Cancer hallmarks intersect with neuroscience in the tumor microenvironment.
Hanahan D; Monje M
Cancer Cell; 2023 Mar; 41(3):573-580. PubMed ID: 36917953
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Neutrophil to lymphocyte ratio and principal component analysis offer prognostic advantage for dogs with mammary tumors.
Uribe-Querol E; Romero-Romero L; Govezensky T; Rosales C
Front Vet Sci; 2024; 11():1395930. PubMed ID: 38756513
[TBL] [Abstract][Full Text] [Related]
6. Mammary Inflammation.
Danforth W
Iowa Med J; 1853 Dec; 1(5):150. PubMed ID: 37677296
[No Abstract] [Full Text] [Related]
7. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
8. Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.
Timmermans-Sprang EPM; Gracanin A; Mol JA
Front Vet Sci; 2017; 4():53. PubMed ID: 28451590
[TBL] [Abstract][Full Text] [Related]
9. Exosome: emerging biomarker in breast cancer.
Jia Y; Chen Y; Wang Q; Jayasinghe U; Luo X; Wei Q; Wang J; Xiong H; Chen C; Xu B; Hu W; Wang L; Zhao W; Zhou J
Oncotarget; 2017 Jun; 8(25):41717-41733. PubMed ID: 28402944
[TBL] [Abstract][Full Text] [Related]
10. The role of COX expression in the prognostication of overall survival of canine and feline cancer: A systematic review.
Gregório H; Magalhães TR; Pires I; Prada J; Carvalho MI; Queiroga FL
Vet Med Sci; 2021 Jul; 7(4):1107-1119. PubMed ID: 33751829
[TBL] [Abstract][Full Text] [Related]
11. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
[TBL] [Abstract][Full Text] [Related]
12. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neoplastic cells outlining the cystic space of invasive micropapillary carcinoma of the canine mammary gland.
Rodrigues MA; Caldeira-Brant AL; Gomes DA; Silveira TL; Chiarini-Garcia H; Cassali GD
BMC Vet Res; 2021 Mar; 17(1):130. PubMed ID: 33761962
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Carcinomas of the Canine Mammary Gland: Histopathological and Immunohistochemical Characteristics.
Nakagaki KYR; Nunes MM; Garcia APV; De Brot M; Cassali GD
Front Vet Sci; 2020; 7():621714. PubMed ID: 33469557
[TBL] [Abstract][Full Text] [Related]
15. Low Stromal Mast Cell Density in Canine Mammary Gland Tumours Predicts a Poor Prognosis.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
J Comp Pathol; 2020 Feb; 175():29-38. PubMed ID: 32138840
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors.
de Souza TA; de Campos CB; De Biasi Bassani Gonçalves A; Nunes FC; Monteiro LN; de Oliveira Vasconcelos R; Cassali GD
Res Vet Sci; 2018 Aug; 119():209-214. PubMed ID: 29966962
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
18. Increased Erythrocyte Sedimentation Rate in Dogs: Frequency in Routine Clinical Practice and Association with Hematological Changes.
Paltrinieri S; Ferrari R; Scavone D; Pieroni C; Diamanti D; Tagliasacchi F
Animals (Basel); 2024 May; 14(10):. PubMed ID: 38791627
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Canine Tumours and the Value of Combined Detection of VEGF, P53, SF and NLRP3 for the Early Diagnosis of Canine Mammary Carcinoma.
Yang NY; Zheng HH; Yu C; Ye Y; Xie GH
Animals (Basel); 2024 Apr; 14(9):. PubMed ID: 38731276
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
